Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Targeted delivery of cytotoxic NAMPT inhibitors using antibody-drug conjugates.

Neumann CS, Olivas KC, Anderson ME, Cochran JH, Jin S, Li F, Loftus LV, Meyer DW, Neale J, Nix JC, Pittman PG, Simmons JK, Ulrich ML, Waight AB, Wong A, Zaval MC, Zeng W, Lyon RP, Senter PD.

Mol Cancer Ther. 2018 Sep 21. pii: molcanther.0643.2018. doi: 10.1158/1535-7163.MCT-18-0643. [Epub ahead of print]

PMID:
30242091
2.

Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability.

Sussman D, Westendorf L, Meyer DW, Leiske CI, Anderson M, Okeley NM, Alley SC, Lyon R, Sanderson RJ, Carter PJ, Benjamin DR.

Protein Eng Des Sel. 2018 Feb 1;31(2):47-54. doi: 10.1093/protein/gzx067.

PMID:
29370435
3.

Pore-scale dispersion: Bridging the gap between microscopic pore structure and the emerging macroscopic transport behavior.

Meyer DW, Bijeljic B.

Phys Rev E. 2016 Jul;94(1-1):013107. doi: 10.1103/PhysRevE.94.013107. Epub 2016 Jul 14.

4.

Testing the Markov hypothesis in fluid flows.

Meyer DW, Saggini F.

Phys Rev E. 2016 May;93(5):053103. doi: 10.1103/PhysRevE.93.053103. Epub 2016 May 9.

PMID:
27300974
5.

A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology.

Jeffrey SC, Burke PJ, Lyon RP, Meyer DW, Sussman D, Anderson M, Hunter JH, Leiske CI, Miyamoto JB, Nicholas ND, Okeley NM, Sanderson RJ, Stone IJ, Zeng W, Gregson SJ, Masterson L, Tiberghien AC, Howard PW, Thurston DE, Law CL, Senter PD.

Bioconjug Chem. 2013 Jul 17;24(7):1256-63. doi: 10.1021/bc400217g. Epub 2013 Jun 28.

PMID:
23808985
6.

Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues.

Burke PJ, Senter PD, Meyer DW, Miyamoto JB, Anderson M, Toki BE, Manikumar G, Wani MC, Kroll DJ, Jeffrey SC.

Bioconjug Chem. 2009 Jun;20(6):1242-50. doi: 10.1021/bc9001097.

PMID:
19469529
7.

Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.

Burke PJ, Toki BE, Meyer DW, Miyamoto JB, Kissler KM, Anderson M, Senter PD, Jeffrey SC.

Bioorg Med Chem Lett. 2009 May 15;19(10):2650-3. doi: 10.1016/j.bmcl.2009.03.145. Epub 2009 Apr 5.

PMID:
19386499
8.

Novel peptide linkers for highly potent antibody-auristatin conjugate.

Doronina SO, Bovee TD, Meyer DW, Miyamoto JB, Anderson ME, Morris-Tilden CA, Senter PD.

Bioconjug Chem. 2008 Oct;19(10):1960-3. doi: 10.1021/bc800289a. Epub 2008 Sep 20.

PMID:
18803412
9.

Sequence and submolecular localization of the 115-kD accessory subunit of the heterotrimeric kinesin-II (KRP85/95) complex.

Wedaman KP, Meyer DW, Rashid DJ, Cole DG, Scholey JM.

J Cell Biol. 1996 Feb;132(3):371-80.

10.

Laparoscopy without pneumoperitoneum. Effects of abdominal wall retraction versus carbon dioxide insufflation on hemodynamics and gas exchange in pigs.

Rademaker BM, Meyer DW, Bannenberg JJ, Klopper PJ, Kalkman CJ.

Surg Endosc. 1995 Jul;9(7):797-801.

PMID:
7482187
11.

Effects of pneumoperitoneum with helium on hemodynamics and oxygen transport: a comparison with carbon dioxide.

Rademaker BM, Bannenberg JJ, Kalkman CJ, Meyer DW.

J Laparoendosc Surg. 1995 Feb;5(1):15-20.

PMID:
7766923
12.

Does transient blocking of axonal conduction occur in uraemic neuropathy?

Meyer DW, Halonen JP, Lang AH, Kuusela V, Forsström J.

J Neurol Neurosurg Psychiatry. 1978 Jun;41(6):525-31.

13.

Serological response of multiple sclerosis patients and controls to 6/94-parainfluenza virus.

Wikström J, Meyer DW, Eickhoff K, Ritter G, Poser S, Bauer HJ.

J Neurol. 1977 Aug 18;216(1):47-50.

PMID:
72793
14.

[A case report on the adult type of recessive spastic paraplegia].

Meyer DW, Hopf HC.

Z Neurol. 1971;199(3):256-8. German. No abstract available.

PMID:
4104409

Supplemental Content

Loading ...
Support Center